stage IIB/C melanomastage IIB/IIC melanomastage IIB/C diseasestage IIB or IIC melanomaPembrolizumabFDAadjuvant immunotherapy
…, 32% of patients in the US received adjuvant immunotherapy for stage IIB/C melanoma and 21% within our healthcare system. The limited dissemination…